These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10530823)

  • 1. Selective activation of group II mGluRs with LY354740 does not prevent neuronal excitotoxicity.
    Behrens MM; Strasser U; Heidinger V; Lobner D; Yu SP; McDonald JW; Won M; Choi DW
    Neuropharmacology; 1999 Oct; 38(10):1621-30. PubMed ID: 10530823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitory mGluR agonist, S-4-carboxy-3-hydroxy-phenylglycine selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal death.
    Buisson A; Choi DW
    Neuropharmacology; 1995 Aug; 34(8):1081-7. PubMed ID: 8532157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonists for group I mGluRs attenuate excitotoxic neuronal death in cortical cultures.
    Strasser U; Lobner D; Behrens MM; Canzoniero LM; Choi DW
    Eur J Neurosci; 1998 Sep; 10(9):2848-55. PubMed ID: 9758154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective activity of the potent and selective mGlu1a metabotropic glutamate receptor antagonist, (+)-2-methyl-4 carboxyphenylglycine (LY367385): comparison with LY357366, a broader spectrum antagonist with equal affinity for mGlu1a and mGlu5 receptors.
    Bruno V; Battaglia G; Kingston A; O'Neill MJ; Catania MV; Di Grezia R; Nicoletti F
    Neuropharmacology; 1999 Feb; 38(2):199-207. PubMed ID: 10218860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of group II metabotropic glutamate receptors results in long-term potentiation following preconditioning stimulation in the dentate gyrus.
    Rush AM; Wu J; Rowan MJ; Anwyl R
    Neuroscience; 2001; 105(2):335-41. PubMed ID: 11672601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective actions of novel and potent ligands of group I and group II metabotropic glutamate receptors.
    Kingston AE; O'Neill MJ; Bond A; Bruno V; Battaglia G; Nicoletti F; Harris JR; Clark BP; Monn JA; Lodge D; Schoepp DD
    Ann N Y Acad Sci; 1999; 890():438-49. PubMed ID: 10668448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, SARs, and pharmacological characterization of 2-amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent, selective, and orally active group II metabotropic glutamate receptor agonists.
    Nakazato A; Kumagai T; Sakagami K; Yoshikawa R; Suzuki Y; Chaki S; Ito H; Taguchi T; Nakanishi S; Okuyama S
    J Med Chem; 2000 Dec; 43(25):4893-909. PubMed ID: 11123999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo evidence for a lack of interaction with dopamine D2 receptors by the metabotropic glutamate 2/3 receptor agonists 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-bicaroxylate monohydrate (LY354740) and (-)-2-oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic acid (LY379268).
    Fell MJ; Perry KW; Falcone JF; Johnson BG; Barth VN; Rash KS; Lucaites VL; Threlkeld PG; Monn JA; McKinzie DL; Marek GJ; Svensson KA; Nelson DL
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1126-36. PubMed ID: 19755662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotection against NMDA excitotoxicity by group I metabotropic glutamate receptors is associated with reduction of NMDA stimulated currents.
    Blaabjerg M; Fang L; Zimmer J; Baskys A
    Exp Neurol; 2003 Oct; 183(2):573-80. PubMed ID: 14552898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.
    Lea PM; Movsesyan VA; Faden AI
    Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective activity of N-acetylaspartylglutamate in cultured cortical cells.
    Bruno V; Wroblewska B; Wroblewski JT; Fiore L; Nicoletti F
    Neuroscience; 1998 Aug; 85(3):751-7. PubMed ID: 9639269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for involvement of group II/III metabotropic glutamate receptors in NMDA receptor-independent long-term potentiation in area CA1 of rat hippocampus.
    Grover LM; Yan C
    J Neurophysiol; 1999 Dec; 82(6):2956-69. PubMed ID: 10601432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-Aminoindan-1,5-dicarboxylic acid and (S)-(+)-2-(3'-carboxybicyclo[1.1.1] pentyl)-glycine, two mGlu1 receptor-preferring antagonists, reduce neuronal death in in vitro and in vivo models of cerebral ischaemia.
    Pellegrini-Giampietro DE; Cozzi A; Peruginelli F; Leonardi P; Meli E; Pellicciari R; Moroni F
    Eur J Neurosci; 1999 Oct; 11(10):3637-47. PubMed ID: 10564371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.
    Monn JA; Valli MJ; Massey SM; Hansen MM; Kress TJ; Wepsiec JP; Harkness AR; Grutsch JL; Wright RA; Johnson BG; Andis SL; Kingston A; Tomlinson R; Lewis R; Griffey KR; Tizzano JP; Schoepp DD
    J Med Chem; 1999 Mar; 42(6):1027-40. PubMed ID: 10090786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective activation of mGlu4 metabotropic glutamate receptors is protective against excitotoxic neuronal death.
    Bruno V; Battaglia G; Ksiazek I; van der Putten H; Catania MV; Giuffrida R; Lukic S; Leonhardt T; Inderbitzin W; Gasparini F; Kuhn R; Hampson DR; Nicoletti F; Flor PJ
    J Neurosci; 2000 Sep; 20(17):6413-20. PubMed ID: 10964947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mGluR7-like receptor and GABA(B) receptor activation enhance neurotoxic effects of N-methyl-D-aspartate in cultured mouse striatal GABAergic neurones.
    Lafon-Cazal M; Viennois G; Kuhn R; Malitschek B; Pin JP; Shigemoto R; Bockaert J
    Neuropharmacology; 1999 Oct; 38(10):1631-40. PubMed ID: 10530824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitotoxicity in the brain.
    Ali C; Nicole O; Docagne F; Lesne S; MacKenzie ET; Nouvelot A; Buisson A; Vivien D
    J Cereb Blood Flow Metab; 2000 Jun; 20(6):956-66. PubMed ID: 10894179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DCG-IV selectively attenuates rapidly triggered NMDA-induced neurotoxicity in cortical neurons.
    Buisson A; Yu SP; Choi DW
    Eur J Neurosci; 1996 Jan; 8(1):138-43. PubMed ID: 8713457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exacerbation of neuronal cell death by activation of group I metabotropic glutamate receptors: role of NMDA receptors and arachidonic acid release.
    Allen JW; Vicini S; Faden AI
    Exp Neurol; 2001 Jun; 169(2):449-60. PubMed ID: 11358458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMDA and non-NMDA receptor-mediated excitotoxicity are potentiated in cultured striatal neurons by prior chronic depolarization.
    Chen Q; Surmeier DJ; Reiner A
    Exp Neurol; 1999 Sep; 159(1):283-96. PubMed ID: 10486197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.